Dr Daniel Chelsky | Chief Scientific Officer
Caprion Proteomics

Dr. Chelsky is the Chief Scientific Officer at Caprion Proteomics, a company using mass spectrometry to discover and validate biomarkers of disease and drug efficacy, drug mechanism of action and new targets for disease intervention.  Previously he served as President of BioSignal, Inc., a subsidiary of PerkinElmer focused on G-protein coupled receptor related research and reagents.  He has also held positions as Sr. Director of Biology at Pharmacopeia, a combinatorial chemistry company, Director of Drug Discovery at Onyx Pharmaceuticals, and Principal Investigator at DuPont Merck Pharmaceuticals.  He received his Ph.D. at the University of Oregon and was an American Cancer Society fellow at the University of California, Berkeley.